Landscape Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Sell
11,035
-10,944
-50% -$930K 0.06% 420
2026
Q1
$1.89M Buy
21,979
+3,574
+19% +$321K 0.12% 264
2025
Q4
$1.61M Buy
+18,405
New +$1.4M 0.11% 282
2024
Q4
Sell
-7,251
Closed -$519K 799
2024
Q3
$519K Sell
7,251
-2,678
-27% -$189K 0.05% 391
2024
Q2
$680K Buy
+9,929
New +$593K 0.06% 411
2023
Q3
Sell
-7,382
Closed -$440K 565
2023
Q2
$440K Buy
+7,382
New +$421K 0.06% 262

Other funds holding GMED

Landscape Capital Management's GMED Position: Q2 2026 in Review

Landscape Capital Management reduced its Globus Medical (GMED) stake by 50% in Q2 2026, selling an estimated $930K and leaving 11,035 shares worth $872K. The position accounts for 0.06% of the portfolio, ranked #420.

Landscape Capital Management first reported a position in GMED in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.89M in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Landscape Capital Management held 11,035 shares of Globus Medical worth $872K as of Q2 2026.
  • Landscape Capital Management sold 10,944 Globus Medical shares in Q2 2026, an estimated $930K.
  • Globus Medical made up 0.06% of Landscape Capital Management's portfolio in Q2 2026, its #420 holding.
  • Landscape Capital Management first reported a position in Globus Medical in Q2 2023 and has held it in 6 quarters since.
  • Landscape Capital Management's Globus Medical position peaked at $1.89M in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.